Cencora/$COR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cencora
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Ticker
$COR
Sector
Health
Primary listing
NYSE
Employees
51,000
Headquarters
Website
Cencora Metrics
BasicAdvanced
$54B
28.77
$9.68
0.58
$2.16
0.79%
Price and volume
Market cap
$54B
Beta
0.58
52-week high
$309.35
52-week low
$218.65
Average daily volume
1.2M
Dividend rate
$2.16
Financial strength
Current ratio
0.905
Quick ratio
0.497
Long term debt to equity
363.986
Total debt to equity
459.175
Dividend payout ratio (TTM)
22.69%
Interest coverage (TTM)
9.58%
Profitability
EBITDA (TTM)
4,555.922
Gross margin (TTM)
3.40%
Net profit margin (TTM)
0.60%
Operating margin (TTM)
1.09%
Effective tax rate (TTM)
25.76%
Revenue per employee (TTM)
$6,210,000
Management effectiveness
Return on assets (TTM)
3.08%
Return on equity (TTM)
116.70%
Valuation
Price to earnings (TTM)
28.77
Price to revenue (TTM)
0.171
Price to book
27.26
Price to tangible book (TTM)
-3.32
Price to free cash flow (TTM)
47.411
Free cash flow yield (TTM)
2.11%
Free cash flow per share (TTM)
5.872
Dividend yield (TTM)
0.78%
Forward dividend yield
0.79%
Growth
Revenue change (TTM)
11.56%
Earnings per share change (TTM)
5.07%
3-year revenue growth (CAGR)
10.24%
10-year revenue growth (CAGR)
9.14%
3-year earnings per share growth (CAGR)
3.58%
10-year earnings per share growth (CAGR)
17.35%
3-year dividend per share growth (CAGR)
5.88%
10-year dividend per share growth (CAGR)
6.93%
What the Analysts think about Cencora
Analyst ratings (Buy, Hold, Sell) for Cencora stock.
Cencora Financial Performance
Revenues and expenses
Cencora Earnings Performance
Company profitability
Cencora News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Aug15
Cencora
Dividend·Ex-dividend
Sept3
Cencora
Dividend·Payment
$0.55Per share
FAQs
What’s the current market cap for Cencora stock?
Cencora (COR) has a market cap of $54B as of August 08, 2025.
What is the P/E ratio for Cencora stock?
The price to earnings (P/E) ratio for Cencora (COR) stock is 28.77 as of August 08, 2025.
Does Cencora stock pay dividends?
Yes, the Cencora (COR) stock pays dividends to shareholders. As of August 08, 2025, the dividend rate is $2.16 and the yield is 0.79%. Cencora has a payout ratio of 22.69% on a trailing twelve-month basis.
When is the next Cencora dividend payment date?
The next Cencora (COR) dividend payment is scheduled for September 03, 2025.
What is the beta indicator for Cencora?
Cencora (COR) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.